早期经尿道前列腺隧道式电切治疗前列腺癌近距离照射治疗术后尿潴留

Saved in:
Bibliographic Details
Published in浙江大学学报：B卷英文版 Vol. 15; no. 8; pp. 756 - 760
Main Author You-yun ZHANG Zhi-gen ZHANG Yan-lan YU Yi-cheng CHEN Kang-xin NI Ming-chao WANG Wei-ping ZHAO Faisal REHMAN Shaw P. WAN Gong-hui LI
Format Journal Article
LanguageEnglish
Published 2014
Subjects
前列腺癌
早期
经尿道前列腺电切
近距离照射治疗
Online AccessGet full text

Cover

More Information
Bibliography:33-1356/Q
Prostate cancer, Brachytherapy, Transurethral resection of the prostate （TURP）
Objective： It is recommended that transurethral resection of the prostate （TURP） after brachytherapy should not be performed at an early stage after implantation. Herein we report our experiences and the results of channel TURP （cTURP） within six months post-implant for patients with refractory urinary retention. Methods： One hundred and ninety patients with localized prostate cancer of clinical stages Tlc to T2c were treated by brachytherapy as monotherapy at our institution from February 2009 to July 2013. Nine patients who developed refractory urinary retention and underwent cTURP within six months after brachytherapy were retrospectively reviewed and analyzed. Results： The median interval between prostate brachytherapy and cTURP was three months （range 1.5 to 5.0 months） There were no intraoperative or postoperative complications and no incontinence resulting from the surgery. All urinary retention was relieved per the American Brachytherapy Society urinary symptom score. With a mean follow-up time of 16 months （range 6 to 26 months） after cTURP, no patient experienced biochemical recurrence. The mean serum prostate-specific antigen （PSA） of the patients who underwent cTURP was 0.42 ng/ml （range 0.08 to 0.83 ng/ml） at the end of their follow-up. Conclusions： Early cTURP was found to be safe and effective in relieving urinary retention after brachytherapy and could be performed without compromising its therapeutic efficacy.
ISSN:1673-1581
1862-1783